Society for Immunotherapy of Cancer
The Society for Immunotherapy of Cancer, previously known as the International Society for Biological Therapy of Cancer, is a professional society of scientists, academicians, researchers, clinicians, government representatives, and industry leaders from around the world dedicated to improving outcomes in patients with cancer by advancing the science and application of cancer immunotherapy. Derived from Wikipedia licensed CC-BY-SA.
Open Access statistics for Society for Immunotherapy of Cancer, United States, covering academic research published from 2003 to 2022. Read More.
Open Access Percentage
95%
Total
Publications
300
Total Open
Publications
286
Total
Citations
2.1K
Open Access
Percentage
95%
Total
Publications
300
Total Open
Publications
286
Total
Citations
2.1K
Breakdown
Publisher Open
0%
Both
95%
Other Platform Open
0%
Closed
5%
Percentage of Open Access over time
Publisher Open
Both
Other Platform Open
Closed
Volume of Open Access over time
Open
Closed
Publisher Open
OA Journal 99%
282
Hybrid 0%
0
No Guarantees 1%
4
Other Platform Open
Domain 100%
284
Institution 11%
30
Other Internet 2%
5
Preprint 0%
0
Public 0%
0
Other Platform Locations
Name | Platform Type | Publications |
|---|---|---|
PubMed Central | Domain | 283 |
Europe PMC | Domain | 283 |
University of Pittsburgh - D-Scholarship@Pitt | Institution | 12 |
Harvard University - Digital Access to Scholarship at Harvard (DASH) | Institution | 5 |
Le Centre pour la Communication Scientifique Directe - HAL - CHU de Clermont-Ferrand | Institution | 3 |
Columbia University - Columbia Academic Commons | Institution | 3 |
Le Centre pour la Communication Scientifique Directe - HAL - Université Paris Descartes | Institution | 2 |
Le Centre pour la Communication Scientifique Directe - HAL - TYPE ART | Other Internet | 2 |
Le Centre pour la Communication Scientifique Directe - HAL - memSIC | Other Internet | 2 |
Le Centre pour la Communication Scientifique Directe - HAL - Inserm | Institution | 2 |